Alumis and Kaken Pharmaceutical Enter Collaboration & Licencing Deal for ESK-001’s Development & Commercialization in Japan

Shots: Alumis & Kaken have partnered to develop, manufacture, & market ESK-001 for dermatology in Japan, with an option to expand into rheumatology & GI diseases As per the deal, Kaken will handle development, approval & marketing of ESK-001 in Japan in exchange for $40M upfront & near-term co-development costs, with ~$140M in milestones & field…

ByRidhi RastogiMarch 25, 2025

NEWS

Zealand Pharma and Roche enter a ~$5.3B Deal to Co-Develop and Commercialize Petrelintide for Weight Management

Shots: Zealand Pharma & Roche will develop & market petrelintide & its products incl. petrelintide + CT-388 (Roche’s asset) in the US & EU for weight loss, with Roche obtaining exclusive marketing rights in the rest of the world Zealand will handle ~50% marketing in the US & EU with opt-in/out rights under specific…

ByRidhi RastogiMarch 12, 2025

NEWS

Nosis Biosciences Partners with Janssen Biotech for Cell-Targeted RNA Drugs

Shots: Nosis Biosciences has entered into a strategic collaboration with Janssen Biotech (subsidiary of J&J) to design & develop cell-targeted RNA medicines The collaboration leverages J&J’s drug discovery & clinical expertise as well as Nosis’ Connexa platform to design drugs with extra-hepatic access to multiple & hard-to-target cell types involved in chronic diseases …

ByRidhi RastogiMarch 12, 2025

NEWS

AbbVie Enters into a Global License Agreement with Gubra to Develop & Commercialize GUB014295 to Treat Obesity

Shots: AbbVie and Gubra entered into a global license agreement to develop & commercialize GUB014295, a potential long-acting amylin analog for obesity treatment As per the deal, AbbVie will lead GUB014295's global development & commercialization, whereas Gubra will get $350M upfront, up to $1.875B development, commercial, sales milestones, with tiered royalties; transaction closure is…

ByRidhi RastogiMarch 4, 2025

NEWS

Bio-Thera Solutions and SteinCares Add Another Biosimilar, Expanding their Alliance

Shots: Bio-Thera Solutions has expanded its collaboration with SteinCares, granting it exclusive rights to market a third biosimilar in Brazil and the LATAM region Bio-Thera will handle development, the US FDA & the EMA submissions to support LATAM regulatory filings & commercial supply of each biosimilar from its Chinese manufacturing facilities SteinCares will utilize its…

ByDipanshu DixitDecember 16, 2024

VIEWPOINTS

Inspiring Innovations: Dino Kazanis and James Swartz in a Stimulating Conversation with PharmaShots

Shots: Thermo Fisher Scientific has recently signed a distribution agreement with Labguru to accelerate research and drive scientific breakthroughs. This collaboration integrates Labguru’s state-of-the-art Electronic Lab Notebook (ELN) with Thermo Fisher Scientific’s comprehensive suite of Laboratory Information Management Systems (LIMS) and lab operations software solutions. By combining ELN and LIMS tools, the partnership aims to…

BySaurabh ChaubeyDecember 11, 2024

THOUGHTSPOT

Pharmacists and Nurses: Working Together for Better Medication Adherence

According to a study, nearly half of all patients with chronic illnesses struggle to take their medications as prescribed, leading to preventable complications, emergency room visits, and, in some cases, hospital admissions. Poor adherence to medications can compromise treatment effectiveness, leading to longer recovery times or, worse, worsening health conditions. It’s clear that healthcare providers…

ByCarla AdamsNovember 6, 2024

EXCLUSIVE

Advancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots

Shots: Arcellx’s Anito-cel, a BCMA CAR-T therapy recently got the FTD, ODD, RMAT designations by the FDA for the treatment of patients with relapsed or refractory multiple myeloma (r/rMM) Today, at PharmaShots we have Chris Heery, Chief Medical Officer at Arcellx, shedding light on Anito-Cel therapy in advancing care for multiple myeloma In late 2022,…

BySaurabh ChaubeySeptember 30, 2024

THOUGHTSPOT

Leaders in Healthcare: How to Work Your Way Up as a Nurse

If you’re an ambitious nursing professional who’s aspiring to become a leader in your field, there are several ways you can make yourself stand out in the industry and work your way up into a leadership position. Employing strategies such as attaining the relevant qualifications in healthcare leadership, for instance - like completing clinical nurse leader…

ByFatima BatoolSeptember 18, 2024

THOUGHTSPOT

LMSW vs. LCSW: What Are the Differences Between These Jobs?

Navigating the different licensure paths when choosing a career in social work can be confusing. For instance, whether aiming to become a Licensed Master Social Worker (LMSW) or a Licensed Clinical Social Worker (LCSW), understanding the nuances of each role is crucial for aligning your career goals with the appropriate qualifications. Hence, this article will…

ByAndrea LaceyAugust 20, 2024

Alumis and Kaken Pharmaceutical Enter Collaboration & Licencing Deal for ESK-001’s Development & Commercialization in Japan

Zealand Pharma and Roche enter a ~$5.3B Deal to Co-Develop and Commercialize Petrelintide for Weight Management

Nosis Biosciences Partners with Janssen Biotech for Cell-Targeted RNA Drugs

AbbVie Enters into a Global License Agreement with Gubra to Develop & Commercialize GUB014295 to Treat Obesity

Bio-Thera Solutions and SteinCares Add Another Biosimilar, Expanding their Alliance

Inspiring Innovations: Dino Kazanis and James Swartz in a Stimulating Conversation with PharmaShots

Pharmacists and Nurses: Working Together for Better Medication Adherence

Advancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots

Leaders in Healthcare: How to Work Your Way Up as a Nurse

Contact US

OUR INFORMATION

FOLLOW US